242 results on '"Sauné, Karine"'
Search Results
2. HIV-1 genotypic resistance testing using single molecule real-time sequencing
3. Human papillomavirus testing using HPV APTIMA® assay and an external cellularity control in self‐collected samples
4. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen
5. A fully automated system using transcription-mediated amplification for the molecular diagnosis of hepatitis E virus in human blood and faeces
6. A European multicenter study on the analytical performance of the VERIS HBV assay
7. BK Viremia and Viruria Does Not Depend on the Type of Double-J Stent Used During Kidney Transplantation.
8. A European multicientre study on the comparison of HBV viral loads between VERIS HBV assay and Roche COBAS® TAQMAN® HBV test, Abbott RealTime HBV assay, Siemens VERSANT HBV assay, and Qiagen artus HBV RG kit
9. A European multicientre study on the comparison of HIV-1 viral loads between VERIS HIV-1 Assay and Roche COBAS® TAQMAN® HIV-1 test, Abbott RealTime HIV-1 Assay, and Siemens VERSANT HIV-1 Assay
10. A European multicentre study on the comparison of HCV viral loads between VERIS HCV assay and COBAS® TaqMan® HCV Test and RealTime HCV Assay
11. Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus
12. Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients
13. Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants
14. Influence of Polyproline Region and Macro Domain Genetic Heterogeneity on HEV Persistence in Immunocompromised Patients
15. Interlaboratory quality control of total HIV‐1 DNA load measurement for multicenter reservoir studies
16. Characteristics of Autochthonous Hepatitis E Virus Infection in Solid-Organ Transplant Recipients in France
17. Genetic Heterogeneity of the NS5A Gene of Hepatitis C Virus and Early Response to Interferon-α
18. Evolution of Human Immunodeficiency Virus Type 1 Populations after Resumption of Therapy following Treatment Interruption and Shift in Resistance Genotype
19. Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy
20. Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers
21. Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy
22. Diagnosis options in patients suffering from COVID‐19‐like symptoms
23. Characterization of CXCR4-using HIV-1 during primary infection by ultra-deep pyrosequencing
24. Frequency of CXCR4-using viruses in primary HIV-1 infections using ultra-deep pyrosequencing
25. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey
26. CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression
27. La diversification de la région hypervariable-1 du virus de l'hépatite C pourrait prédire l'évolution de la fibrose hépatique après transplantation rénale
28. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients
29. Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract
30. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism
31. Serum Concentrations of Ribavirin and Pegylated Interferon and Viral Responses in Patients Infected With HIV and HCV
32. Genetic Diversity of HCV Genotype 2 Strains in South Western France
33. Twenty-Four Hour Kinetics of Hepatitis C Virus and Antiviral Effect of Alpha-Interferon
34. Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART
35. Incidence of HCV Infection in French Hemodialysis Units: A Prospective Study
36. Effects of long-term lamivudine therapy in renal-transplant patients
37. Amantadine therapy in renal transplant patients with hepatitis C virus infection
38. Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology
39. Genotypic prediction of HIV-1 subtype D tropism
40. Evolution of Total and Integrated HIV-1 DNA and Change in DNA Sequences in Patients with Sustained Plasma Virus Suppression
41. Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene
42. Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients
43. A European multicientre study on the comparison of HBV viral loads between VERIS HBV assay and Roche COBAS ® TAQMAN ® HBV test, Abbott RealTime HBV assay, Siemens VERSANT HBV assay, and Qiagen artus HBV RG kit
44. European Multicenter Study on Analytical Performance of Veris HIV-1 Assay
45. Malignancies in hepatitis C virus-positive and -negative kidney transplant recipients: A case-controlled study
46. A European multicentre study on the comparison of HCV viral loads between VERIS HCV assay and COBAS ® TaqMan ® HCV Test and RealTime HCV Assay
47. European Multicenter Study on Analytical Performance of DxN Veris System HCV Assay
48. Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use
49. Analytical performance of the VERIS MDx system HCV assay for detecting and quantifying HCV RNA
50. Quantification of HEV RNA by Droplet Digital PCR
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.